Fritextsökning
Innehållstyper
-
Recipharm divests five Swedish plants
Swedish contract manufacturer Recipharm is selling its facilities in Solna, Strängnäs, Höganäs, Karlskoga and Uppsala OTC Development to US private equity compa...
-
Organize and Manage Digital Classrooms
Create engaging lessons with ZEISS Labscope Teacher.
-
Forskaren in Hagastaden now inagurated
The real estate company Vectura's life science center in Hagastaden, Forskaren, is now inaugurated. The opening was attended by people from the industry, politi...
-
Lucy Robertshaw: Did you know Stockholm wants to be in top 5 in the world for Life Sciences?
Karolinska Institutet Solna Campus has certainly become the next “Kendall Square”, writes Lucy Robertshaw in a column.
-
Study: Vaccination linked to lower risk of post-COVID
The risk of developing post-COVID after a COVID infection was reduced in vaccinated people, according to a new study from the University of Gothenburg.
-
Life Science Sweden´s international issue is on its way
A new issue of Life Science Sweden is on its way to print, packed with news, interviews and reports.
-
Marie Gårdmark: ”Interchangeable biological medicines – soon in a pharmacy near you?”
”Generic competition is an effective way to push down drug prices, but it has not worked equally well for biosimilars. Biosimilars require more time to gain mar...
-
Efficient use of blood plasma
Blood plasma is an indispensable resource in the production of life-saving medicines. It is in high demand on global markets. To make more efficient use of this...
-
AI-Driven Microscopy Image Analysis in Pharma and Biotech
Extract breakthrough discoveries from large, complex data sets.
-
Fast Optical Sectioning of Developing Organisms and Tissue Microstructures
ZEISS Lattice SIM 3 exploits the full potential of the SIM Apotome technology.
-
Trender inom life science 2025 – Del 3 ekonomin
Kommande patentutgångar driver läkemedelsbolagen att förvärva under 2025. I Sverige kan vi vara på väg mot ljusare tider och färre konkurser. Del 3 i serien med...
-
A new giant among our microscopes
Two technologies in one machine.
-
Ny mpox-variant sprids från Kongo – ökad efterfrågan på vaccin
En dödligare variant av mpox sprids från Demokratiska Republiken Kongo och utgör en risk för barn. Viruset orsakar feber, huvudvärk, muskelvärk, smärtsamma böld...
-
Ozempic may benefit hip replacement surgery
The high-profile drug for type 2 diabetes and weight loss may be beneficial in other areas. One such area is for patients undergoing hip replacement surgery, a new study suggests....
-
Novo Nordisk to invest billions in Danish manufacturing facilities
Danish pharmaceutical giant Novo Nordisk is investing DKK 42 billion, equivalent to around SEK 65 billion/EUR 5.6 billion, in its manufacturing facilities in Ka...
-
Don't miss ZEISS Quality Innovation Days
Digital event April 15-19, 2024.
-
Try arivis for free
30-day free trial offers a number of benefits.
-
It couldn’t be simpler
AI-assisted ZEISS Solution inspects implant coatings automatically.
-
From Valneva to the CEO position at NorthX – “I saw it as a great opportunity”
A new cell therapy for leukaemia, a vaccine in tablet form against cholera, and a proprietary mRNA line with the potential capacity to supply the entire Nordic ...
-
A mass flow controller that is silent, fast and cost-effective
Portable ventilator breathing devices, bioreactors or the dosing of inert gases all rely on the highest control dynamics. That is exactly what the proportional ...
-
ZEISS presents the "Quality Innovation Days"
The digital event for metrology and software.
-
The first vaccine derived from cowpox
The British rural doctor could not forget the words of the peasant girl. Could that really be true? A couple of decades later, on 14 May 1796, he performed the ...
-
Behöver du vätskekylning under noll grader?
SMC erbjuder cirkulationskylare för en rad olika appikationer och temperaturer, minusgrader inkluderat. Kontakta oss så hittar vi rätt lösning för dig!
-
Medical device quality assurance
Recordings from ZEISS Quality Innovation Days.
BREAKING